Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 38%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Holdings Inc. reported a revenue rate of $495.43, reflecting a 0.6% increase, with a gross margin growth of 32.6%, exceeding expectations due to improved administrative cost management. The company achieved strong performances across its segments, notably in Private Duty Services, which saw revenue growth of 25.6% to $514.4 million, and Home Health & Hospice, which grew 15.3% year-over-year to $62.4 million, driven by significant increases in admissions. Additionally, the firm has improved cash flow and financial flexibility, raising its revenue guidance to above $2.375 billion, indicating confidence in ongoing operational execution and strategic initiatives.

Bears say

The analysis of Aveanna Healthcare Holdings Inc. indicates several fundamental challenges contributing to a negative outlook for the company's stock. Key concerns include potential reimbursement pressures, high leverage, increased competition, and continued labor headwinds, which are projected to drive a 10% downside to the base case FY26 adjusted EBITDA estimate. Furthermore, while the company reported better-than-expected revenue of $45.1 million, the gross margin declined to 45.0%, raising questions about profitability amidst operational hurdles and regulatory issues.

AVAH has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 38% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 8 analysts, AVAH has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.56, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.56, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.